Endolymphatic hydrops perspectives 2012
Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years. Hydrops has historically been a diagnosis of exclusion...
Gespeichert in:
Veröffentlicht in: | Current opinion in otolaryngology & head and neck surgery 2012-10, Vol.20 (5), p.416-419 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Endolymphatic hydrops remains a significant cause of morbidity secondary to vertigo, hearing loss, and tinnitus. The purpose of this report is to summarize the most clinically relevant publications on endolymphatic hydrops over the past 2 years.
Hydrops has historically been a diagnosis of exclusion, but recent efforts has shown a role for MRI with intratympanic gadolinium. Cochrane reviews of intratympanic dexamethasone and gentamicin found inadequate level 1 evidence to support their use.
High-level evidence to guide therapy is lacking. MRI holds potential for definitive diagnosis. |
---|---|
ISSN: | 1068-9508 1531-6998 |
DOI: | 10.1097/MOO.0b013e328357a6c8 |